Kymera Therapeutics, Inc.

KYMRCIK 0001815442 · Every Form 4 filed by insiders at this issuer.

Filings

9

Latest Mar 15, 2024

Unique insiders

20

Showing

9 of 9

Page 1

Top insiders

Most active reporters at Kymera Therapeutics, Inc.

All filings

9 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 15, 2024
Booth Bruce
Director
S49,591$40.62$2,014,386
Mar 13, 2024
Booth Bruce
Director
S126,066$41.94$5,287,208
Mar 13, 2024
Atlas Venture Fund X, L.P.
10% Owner
S126,066$41.94$5,287,208
Mar 4, 2024
Chiniara Ellen
Chief Legal Officer
A21,755$0.00$0
Mar 4, 2024
Chadwick Jeremy G
Chief Operating Officer
A13,425$0.00$0
Feb 21, 2024
Albers Jeffrey W.
Director
S4,385$39.0483$171,227
Jan 23, 2024
Albers Jeffrey W.
Director
S10,000$30.047$300,470
Jan 9, 2024
BVF PARTNERS L P/IL
Director · Other
Holdings only
Jan 5, 2024
Chiniara Ellen
Chief Legal Officer
S3,295$22.5844$74,416

Showing 19 of 9

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.